Abbott Laboratories Message Board
-
Report was mildly disappointing and stock price had gone up too much too soon. If there is no market swoon, I think price will base around $26-27. If there is a significant market pullback, who knows how low it can go. I believe there will be a correction very soon, but I doubt it will be very significant, due to Central Bank liquidity. So, PFE should base during the company's 2Q and move back above $30 by next report.
-
Maybe, but it is likely to get cheaper in coming days with broker downgrades that are sure to follow. This was a big disappointment to shareholders, and most regret not selling earlier. Any temporary strength will result in selling.
-
IMO $54
- Reply to
The more obvious it becomes that the US can't pay back it's bonds the more people buy
by bigg_redd_rockett •Apr 5, 2013 10:05 AMThe Fed is gradually replacing bondholders with its own balance sheet, which never has to be paid back. The eventual rate rise will be in spite of Fed actions, not because of them.
-